Fosinopril Sodium — Discount Pricing
Fosinopril Sodium is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Fosinopril Sodium Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $68.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Fosinopril Sodium
Fosinopril Sodium is a prescription medication. Ask your doctor if Fosinopril Sodium is right for you.
Other strengths and forms of Fosinopril
Conditions Treated with Fosinopril Sodium
How to Check Fosinopril Sodium Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Fosinopril Sodium at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
About Fosinopril Sodium
Fosinopril sodium is a vital medication prescribed for managing high blood pressure and certain heart conditions. For many, the ongoing cost of essential prescriptions can be a significant burden. TheDrugClub is committed to making healthcare accessible and affordable, offering members incredible savings, including access to fosinopril sodium with a $0 co-pay and convenient free home delivery.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Fosinopril Sodium is approved for (FDA label)
Fosinopril sodium tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ) . In using fosinopril sodium tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril sodium tablets do not have a similar risk (see WARNINGS ).
Source: Read the full FDA label on DailyMed. Label effective date: October 10, 2025.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Boxed warning for Fosinopril Sodium (FDA label)
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue fosinopril sodium tablets as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS , Fetal Toxicity .
Source: FDA prescribing information (DailyMed). Set ID: ff1323cc-7ad8-488d-94a7-a11555db78a7. SPL document ID: 40d2b698-02dc-4589-e063-6394a90afb52. Label effective date: October 10, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Fosinopril Sodium (FDA label)
Fosinopril sodium has been evaluated for safety in more than 2,100 individuals in hypertension and heart failure trials, including approximately 530 patients treated for a year or more. Generally, adverse events were mild and transient, and their frequency was not prominently related to dose within the recommended daily dosage range. Hypertension In placebo-controlled clinical trials (688 fosinopril sodium-treated patients), the usual duration of therapy was two to three months. Discontinuations due to any clinical or laboratory adverse event were 4.1% and 1.1% in fosinopril sodium-treated and placebo-treated patients, respectively. The most frequent reasons (0.4% to 0.9%) were headache, elevated transaminases, fatigue, cough (see PRECAUTIONS, General, Cough ), diarrhea, and nausea and vomiting.
Source: FDA prescribing information (DailyMed). Set ID: ff1323cc-7ad8-488d-94a7-a11555db78a7. SPL document ID: 40d2b698-02dc-4589-e063-6394a90afb52. Label effective date: October 10, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.